Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Docetaxel Plus Carboplatin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2001
by National Cancer Institute (NCI).
Recruitment status was Active, not recruiting
Study NCT00003562 Information provided by National Cancer Institute (NCI)
First Received on November 1, 1999. Last Updated on December 3, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
Carcinoma, Non-Small-Cell Lung
More general conditions related to this trial
Neoplasms by Site
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Interventions listed in this trial
More general drug interventions related to this trial
Sponsors listed in this trial
Hope Cancer Institute, Inc.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers